<html>
<head>PUBMED IDs for DDX43</head>
<body bgcolor='#C5F0F2'><h1>DDX43</h1><a href='https://pubmed.ncbi.nlm.nih.gov/17312182/'>Cancer/testis genes in multiple myeloma: expression patterns and prognosis value determined by microarray analysis.</a> February 22  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/20726502/'>A panel of cancer-testis genes exhibiting broad-spectrum expression in haematological malignancies.</a> October 27  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/24573400/'>Novel cancer-testis antigen expression on glioma cell lines derived from high-grade glioma patients.</a> October 29  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24656837/'>DDX43 promoter is frequently hypomethylated and may predict a favorable outcome in acute myeloid leukemia.</a> June 15  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24899684/'>Overexpression of DDX43 mediates MEK inhibitor resistance through RAS Upregulation in uveal melanoma cells.</a> May 12  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/26575221/'>Brain-specific epigenetic markers of schizophrenia.</a> July 20  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/28342986/'>Oncogenic roles of DNA hypomethylation through the activation of cancer-germline genes.</a> March 27  2017<br></body></html>
